Sarah Monz

Sarah Monz, MD, Co-CEO at Iscador AG and specialist in integrative medicine.

Sarah Monz

Sarah Monz, MD, is a distinguished physician and corporate leader who stands at the nexus of conventional medicine and integrative health. As Co-CEO of Iscador AG and a specialist in anesthesiology, pain therapy, Traditional Chinese Medicine, and Functional Medicine, she brings a uniquely comprehensive perspective to patient care and healthcare strategy. Her work embodies the principles of evidence-based integration, seeking to create resilient health solutions for complex chronic conditions.

Dr. Monz’s multifaceted expertise aligns powerfully with the 3rd WCTCIM’s focus on bridging knowledge systems. Consequently, her leadership in a prominent integrative medicine company and her deep clinical background offer invaluable insights into translating traditional practices into safe, effective, and scalable modern healthcare solutions.


Biography and Expertise of Sarah Monz

Dr. Sarah Monz represents a new generation of medical leaders who skillfully navigate both the world of acute, conventional medicine and the holistic landscape of Traditional, Complementary, and Integrative Medicine (TCIM). Her foundation as a board-certified anesthesiologist and pain specialist provides her with deep insights into the physiological mechanisms of pain and stress. Beyond this, her extensive training in Traditional Chinese Medicine (TCM), Functional Medicine, and Mitochondrial Medicine allows her to address the root causes of illness by considering the patient as a whole, interconnected system.

This synthesis of disciplines is central to her approach and directly supports the 3rd WCTCIM’s motto, “Knowledge Diversity.” Her work is a living example of the Thematic Axis, “Integration of TCIM into Health Systems,” demonstrating how ancient wisdom and modern science can be combined in clinical practice. Furthermore, her certification as a Nature Resilience Trainer connects her expertise to the axis of “Planetary Health,” highlighting the critical link between human well-being and a healthy environment. Therefore, the career of Sarah Monz exemplifies the creation of “Well-being Societies” through a truly integrative and sustainable vision for health.

Professional Career

Dr. Sarah Monz‘s professional journey reflects a transition from clinical care to executive leadership. With a foundation in anesthesiology and pain management in Germany and Switzerland, she gained experience with complex medical cases. This clinical background became the bedrock for her expertise in integrative modalities and broader patient care.

Her move to executive roles at Iscador AG, a leader in anthroposophic medicine, marked a shift toward influencing the broader healthcare landscape. This demonstrates her commitment to patient outcomes and advancing institutional frameworks to make integrative medicine more accessible and scientifically robust. Each role has expanded her capacity to drive change.

  • 2025 – Present: Co-CEO, Iscador AG, Arlesheim, Switzerland. Co-directs the company’s strategy, medical affairs, and global vision, steering its mission to provide evidence-based integrative therapies.
  • 2019: Member of the Executive Board, Medicine & Communications, Iscador AG. Oversaw the company’s medical and scientific integrity and led communication strategies to engage healthcare professionals and the public.
  • 2016: Functional Medicine Specialist at Paramed AG, Baar, Switzerland. Applied systems-biology principles to diagnose and treat complex chronic diseases, focusing on personalized care.
  • 2014: Anesthesiologist and board-certified Pain Specialist, Lich, Germany. Managed acute and chronic pain, combining conventional and complementary approaches to improve patient quality of life.
  • 2010: Board-certified Anesthesiologist, Germany and Switzerland. Began her specialized career, mastering critical care and perioperative medicine in demanding hospital settings.

Academic Qualifications

Dr. Sarah Monz‘s diverse academic foundation shows a dedication to lifelong learning. She began with conventional medicine and augmented it with qualifications in TCIM fields, building a comprehensive skill set.

This background enables her to design truly holistic strategies. Her commitment to an evidence-informed, integrated approach provides the credibility and expertise to lead in this evolving field.

  • 2024: M.Sc. in Integrative Healthcare, The National Centre of Integrative Medicine, UK. Pinnacle of her formal training, providing advanced academic and research skills in integrative health.
  • 2022: Board Certification, Nature Resilience Trainer, Germany Academy of Forest Bathing and Health. Highlights her focus on the therapeutic benefits of nature for mental and physical resilience.
  • 2016: Board Certification, Pain Medicine, Germany. Solidified her expertise in managing one of the most challenging areas of medicine.
  • 2015: PGD in Mitochondrial and Environmental Medicine, Germany. Specialized knowledge in the cellular basis of health and environmental factors in disease.
  • 2010: Board Certification, Anesthesiology, Germany. Formal recognition of her specialty in anesthesiology.
  • 2005: Medical State Exam, Justus Liebig University, Germany. Completion of her foundational medical training.
  • 2005: PGD in Acupuncture and Traditional Chinese Medicine, Germany. Demonstrates her early interest in integrating traditional systems with medical practice.

Research and Publications

Dr. Sarah Monz‘s scholarly contributions, though focused, reveal a deep-seated interest in exploring the scientific underpinnings and practical applications of integrative therapies. Her publications address a range of topics, from the biochemical effects of traditional herbal preparations to the application of TCIM in humanitarian crises. This research activity demonstrates a commitment to building the evidence base that is essential for the wider acceptance and integration of these modalities into mainstream healthcare.

A key theme in her work is the investigation of tangible, measurable outcomes. For instance, her study on a Tibetan herbal composition’s effect on kynurenine metabolism delves into the biochemical pathways through which traditional remedies may exert their effects. This aligns perfectly with the Gujarat Declaration’s emphasis on science and evidence. Similarly, her publication on using NADA acupuncture and somatic therapy for trauma relief in the Philippines showcases the vital role of TCIM in global public health, particularly in low-resource and disaster-stricken settings. This work by Sarah Monz provides practical models for scalable, non-pharmacological interventions.

Her co-authored articles on pain therapy and gut health further underscore her focus on foundational pillars of integrative and functional medicine. These publications contribute to the professional discourse and provide other clinicians with valuable insights. Therefore, her research efforts help bridge the gap between traditional knowledge and contemporary scientific validation, a core mission of the 3rd WCTCIM.

Leadership and Strategic Vision

Beyond her clinical and academic achievements, Dr. Sarah Monz exercises significant influence through her executive leadership roles. Her position on the Executive Board and subsequent appointment as Co-CEO of Iscador AG place her at the helm of one of Europe’s well-established companies in the field of integrative medicine, particularly known for its work in anthroposophic oncology. This is not merely a corporate role; it is a platform for shaping the future of integrative healthcare on a large scale.

In these capacities, she is responsible for guiding the company’s medical strategy, ensuring that its products and educational initiatives are grounded in scientific evidence and meet the highest standards of quality and safety. This work involves navigating the complex regulatory landscapes of multiple countries, fostering research collaborations, and advocating for the inclusion of integrative therapies in standard care guidelines. Her affiliation with the Society for Cancer Research (VfK) further solidifies her commitment to advancing evidence-based approaches in integrative oncology.

The leadership of Sarah Monz is therefore instrumental in operationalizing the goals of the WHO Traditional Medicine Strategy. By steering a major organization in the sector, she contributes directly to the sustainable development, production, and integration of TCIM products and practices. Her work provides a powerful example of how strategic corporate leadership can drive the mission of integrating traditional and complementary medicine into global health systems.

Connect with Dr. Monz

For more detailed information on the work, research, and professional activities of Dr. Sarah Monz, you can explore her official corporate profile and connect with her through professional networks. These resources offer further insights into her leadership in the field of integrative medicine and her vision for the future of healthcare.

Official Profile at Iscador AG: View Executive Profile

LinkedIn Profile: Connect on LinkedIn

Speaker Details
Leave a Comment

Speaker Details